Page last updated: 2024-11-11

crabrolin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

crabrolin: tridecapeptide from venom of hornet Vespa crabro; releases histamine from rat peritoneal mast cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5487899
MeSH IDM0125540

Synonyms (5)

Synonym
crabrolin
phe-leu-pro-leu-ile-leu-arg-lys-ile-val-thr-ala-leunh2
93207-22-8
mast cell degranulating peptide hr ii (vespa orientalis), 7-l-arginine-9-l-isoleucine-11-l-threonine-12-l-alanine-13-de-l-leucine-
DTXSID40239337

Research Excerpts

Overview

Crabrolin is a tridecapeptide extracted from the venom of the European hornet.

ExcerptReferenceRelevance
"Crabrolin is a tridecapeptide extracted from the venom of the European hornet ("( A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity.
Chen, T; Chen, X; Ma, C; Ma, Y; Shaw, C; Sun, R; Wang, L; Yao, A; Zhou, M; Zou, W, 2023
)
1.89
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's3 (42.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.28 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]